Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Amendment

12 Dec 2018 12:16

RNS Number : 2773K
Citigroup Global Markets Limited
12 December 2018
 

 

 

 

Amendment - Section 2(a) & (b)

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH

RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Citigroup Global Markets Limited

(b) Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exemptprincipal trader is connected:

Shire plc

(d) Date dealing undertaken:

10 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?If it is a cash offer or possible cash offer, state "N/A"

YESTakeda Pharmaceutical Company Limited

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

5p ordinary

Purchase

134,770

USD 57.3978

USD 57.1929

5p ordinary

Purchase

3,926,389

GBP 45.3200

GBP 44.8800

5p ordinary

Sale

24,000

USD 57.3978

USD 57.3978

5p ordinary

Sale

561,503

GBP 45.3200

GBP 44.8400

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealinge.g. opening/closing along/short position,increasing/reducing along/short position

Number of reference securities

Price per unit

5p ordinary

TRS

Increasing Short Position

26,344

USD 57.1929

5p ordinary

TRS

Increasing Short Position

10,426

USD 57.2578

5p ordinary

TRS

Increasing Short Position

50,000

USD 57.2795

5p ordinary

TRS

Reducing Long Position

442,300

GBP 44.9206

5p ordinary

TRS

Reducing Long Position

630,478

GBP 44.9206

5p ordinary

TRS

Increasing Short Position

1

GBP 45.0486

5p ordinary

TRS

Reducing Short Position

1

GBP 45.0500

5p ordinary

TRS

Increasing Short Position

137

GBP 45.0704

5p ordinary

TRS

Reducing Short Position

2,535

GBP 45.0000

5p ordinary

TRS

Reducing Short Position

35

GBP 45.0000

5p ordinary

TRS

Increasing Short Position

5

GBP 45.0750

5p ordinary

TRS

Increasing Short Position

6

GBP 45.0700

5p ordinary

TRS

Increasing Short Position

206

GBP 45.0700

5p ordinary

TRS

Increasing Short Position

150

GBP 45.0700

5p ordinary

TRS

Increasing Short Position

27

GBP 45.0752

5p ordinary

TRS

Increasing Short Position

98

GBP 45.0751

5p ordinary

TRS

Increasing Short Position

1,407

GBP 45.0000

5p ordinary

TRS

Reducing Short Position

416

GBP 45.0000

5p ordinary

TRS

Increasing Long Position

224

GBP 44.9215

5p ordinary

TRS

Increasing Long Position

33

GBP 45.0252

5p ordinary

TRS

Increasing Long Position

230

GBP 44.9300

5p ordinary

TRS

Increasing Long Position

16

GBP 45.1200

5p ordinary

TRS

Increasing Long Position

208

GBP 45.0415

5p ordinary

TRS

Increasing Long Position

934

GBP 44.9768

5p ordinary

TRS

Increasing Long Position

30

GBP 45.0400

5p ordinary

TRS

Increasing Long Position

30

GBP 44.9000

5p ordinary

TRS

Increasing Long Position

27

GBP 44.9300

5p ordinary

TRS

Increasing Long Position

215

GBP 45.0965

5p ordinary

TRS

Increasing Long Position

303

GBP 44.9567

5p ordinary

TRS

Increasing Long Position

30

GBP 45.0250

5p ordinary

TRS

Increasing Long Position

90

GBP 44.9000

5p ordinary

TRS

Increasing Long Position

18

GBP 44.9200

5p ordinary

TRS

Increasing Long Position

223

GBP 44.9165

5p ordinary

TRS

Increasing Long Position

219

GBP 45.0715

5p ordinary

TRS

Increasing Long Position

242

GBP 44.9415

5p ordinary

TRS

Reducing Long Position

493,022

GBP 44.9206

5p ordinary

TRS

Reducing Long Position

1,806,051

GBP 44.9200

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing,selling,varying etc.

Number of securities towhich option relates

Exercise price per unit

Typee.g. American,European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number ofsecurities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit(if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,formal or informal, relating to relevant securities which may be an inducement to dealor refrain from dealing entered into by the exempt principal trader making thedisclosure and any party to the offer or any person acting in concert witha party to the offer:

 

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, betweenthe exempt principal trader making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

12 December 2018

Contact name:

Connor McLaughlin

Telephone number:

02895 955 328

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERTTBTTMBBBBIP
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.